Loading patent…
AssigneeShenzhen Protgen Ltd.
InventorsYongzhang Luo, Yan Fu, Hongyi Liu, Anji Ju, Jiaze Tang, Yi Jiang, Boyuan Ma, Xiaoqin Jiang, Yu Feng, Guodong Chang, Hui Li
Estimating the term…
Provided is the use of human serum albumin in the manufacturing of a drug for treating diabetes, obesity, atherosclerosis, Alzheimer's disease, Parkinson's disease and other diseases. In a preferred embodiment, the human serum albumin is the recombinantly prepared young and uninjured human serum albumin, and has achieved excellent effects in reducing the blood sugar level of a diabetic patient.
-11. (canceled)
A method of treating a disease, comprising administering to a subject a therapeutically effective amount of human serum albumin (HSA), wherein the disease is selected from the group consisting of diabetes mellitus, obesity, atherosclerosis, Alzheimer's disease, and Parkinson's disease.
-14. (canceled)
Dependencies are inferred from the claim text.